TransMedics competitors

I am the Chief Executive Officer, President and Chairman of Abiomed, Inc. (NASDAQ: ABMD), the only medical device company focused solely on heart recovery. At Abiomed, we are driven by our four principles: recovering hearts and saving lives, leading in technology and innovation, growing shareholder value and sustaining a winning culture of putting patients first. As a U.S. military veteran, I also serve as Co-Founder and Chairman of the Mentoring Veterans Program (MVPvets), a nonprofit organization committed to helping military veterans network with industry mentors to discover career opportunities in the life sciences industry.

Robert Kramer is a President & Chief Executive Officer at EMERGENT BIOSOLUTIONS INC., Board Member at EMERGENT BIOSOLUTIONS INC., and Interim Exec VP:Services at EMERGENT BIOSOLUTIONS INC. and is based in Lansing, Michigan. He has experience at PHARMACIA CORP and has worked as Pres:Biosciences Div at EMERGENT BIOSOLUTIONS INC., Consultant at EMERGENT BIOSOLUTIONS INC., and President at Emergent Biodefense Ops Lansg. Robert works or has worked as Chief Executive Officer at Emergent Biodefense Operations. He studied at WESTERN KENTUCKY UNIVERSITY between 1980 and 1983 and Clemson University between 1975 and 1979.

Insightful and visionary, I have a broad understanding and appreciation of how complex, sophisticated inner-workings of global medtech businesses function. At my core, I’m an engineer who can invent, solve problems, and get the job done. My natural talent is in technology, product development and organizational leadership and I’ve proven that time and again through innovation and commercialization of products from concept to market and building sustainable global teams.As a senior executive leading highly technical organizations, my career has been blending strategic vision, operational insight, and leadership. I deliver results that consistently strengthen the business model by engaging technical strategy and the global business environment with corporate goals.Because I have an entrepreneurial spirit, I do what it takes in various functions across the business spectrum - especially through product development, business management, technology and global collaborations.Mentoring and developing next generation leaders are a top priority of mine, I foster a culture of learning within multicultural-based operations. My personal vision as a leader is to build an excellent team with strong ideas and implementation capabilities that inspire teams, colleagues, and leaders.I have personal knowledge and understanding of multi-cultural market dynamics, international business relations, organizational mechanics, corporate competitiveness and global business strategy.Global Cross-functional, Cross-cultural Leadership | Program Management | Broad Technology Knowledge | Strategic Planning | Financial and Business Control & P&L Management | Business Development, M&A | Robotic Surgery | Digital SurgeryCredentials: MBA, MSc, BSc

Lloyd Sanders joined Epic Sciences as President and Chief Executive Officer in 2019 with more than 20 years of diagnostics and pharmaceutical industry experience, most of it focused on oncology. Prior to joining Epic, he served as president of the oncology segment of Myriad Genetics, overseeing the oncology, urology and dermatology commercial organizations. While at Myriad, he was responsible for the sales, marketing, medical, customer service and laboratory operations for numerous market-leading commercial products, including molecular diagnostics for risk assessment, diagnosis/screening, prognosis and selection of therapies for breast, prostate, colorectal and other cancers. Previously, Mr. Sanders served as chief operating officer at Dey Pharma, a division of Mylan, overseeing sales, marketing and medical affairs, including the EpiPen® flagship brand. Prior to Dey Pharma, he held several leadership positions including responsibility for the commercial growth of a number of oncology products at Sanofi-Synthelabo, subsequently Sanofi-Aventis, where he led the successful restructuring and integration of two companies’ sales forces after the merger. Mr. Sanders started his pharmaceutical career and participated in oncology product launches at Pharmacia (now Pfizer). Mr. Sanders earned a Bachelor’s business degree with an emphasis in marketing from Memphis State University.